39 institutions reported holding $5.2M of TRAWS PHARMA INC (TRAW) in SEC 13F filings for 2026-06-30. Largest institutional holders: ORBIMED ADVISORS LLC ($1.0M), Ally Bridge Group (NY) LLC ($663,033), ADAGE CAPITAL PARTNERS GP, L.L.C. ($615,609), ADAR1 Capital Management, LLC ($504,065), Lynx1 Capital Management LP ($471,801). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30